CARLSMED INC (CARL) Stock Price & Overview
NASDAQ:CARL • US14280C1053
Current stock price
The current stock price of CARL is 10.8 USD. Today CARL is up by 0.47%. In the past month the price increased by 3.37%.
CARL Key Statistics
- Market Cap
- 288.684M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -1.22
- Dividend Yield
- N/A
CARL Stock Performance
CARL Stock Chart
CARL Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to CARL.
CARL Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to CARL. While CARL seems to be doing ok healthwise, there are quite some concerns on its profitability.
CARL Earnings
On February 25, 2026 CARL reported an EPS of -0.32 and a revenue of 15.16M. The company beat EPS expectations (26.36% surprise) and beat revenue expectations (2.52% surprise).
CARL Forecast & Estimates
11 analysts have analysed CARL and the average price target is 19.58 USD. This implies a price increase of 81.33% is expected in the next year compared to the current price of 10.8.
For the next year, analysts expect an EPS growth of 34.36% and a revenue growth 46.05% for CARL
CARL Groups
Sector & Classification
CARL Financial Highlights
Over the last trailing twelve months CARL reported a non-GAAP Earnings per Share(EPS) of -1.22. The EPS decreased by -126.74% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -23.22% | ||
| ROE | -30.56% | ||
| Debt/Equity | 0.16 |
CARL Ownership
CARL Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 14.72 | 161.117B | ||
| ISRG | INTUITIVE SURGICAL INC | 41.93 | 160.285B | ||
| SYK | STRYKER CORP | 22.03 | 125.349B | ||
| BSX | BOSTON SCIENTIFIC CORP | 18.47 | 88.457B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.85 | 45.956B | ||
| IDXX | IDEXX LABORATORIES INC | 39.12 | 45.191B | ||
| BDX | BECTON DICKINSON AND CO | 11.39 | 44.616B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.81 | 32.972B | ||
| RMD | RESMED INC | 18.11 | 32.227B | ||
| DXCM | DEXCOM INC | 24.88 | 24.092B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.09 | 17.942B | ||
| PODD | INSULET CORP | 29.9 | 13.321B | ||
| PEN | PENUMBRA INC | 65.23 | 12.858B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About CARL
Company Profile
Carlsmed, Inc. engages in the development of AI based technology solutions to the medical industry. The company is headquartered in Carlsbad, California and currently employs 127 full-time employees. The company went IPO on 2025-07-23. Its aprevo technology platform offers solutions for the entire surgical workflow, including pre-operative AI-enabled, surgical planning; intra-operative advanced visualization to support precision placement of aprevo interbody implants, and post-operative data collection and insights intended to improve the digital surgical planning process. Its pre-operative planning software utilizes standard-of-care diagnostic imaging and AI-enabled algorithms to develop personalized digital surgical plans and to design aprevo interbody implants for each patient's pathology and vertebral bone topography. Additionally, the aprevo technology platform supports the collection of real-world, post-operative data to inform its digital surgical planning process. Its platform is commercially available in the United States and is indicated for use in lumbar interbody fusion procedures.
Company Info
IPO: 2025-07-23
CARLSMED INC
1800 Aston Ave., Suite 100
Carlsbad CALIFORNIA US
Employees: 127
Phone: 13022880670
CARLSMED INC / CARL FAQ
What does CARLSMED INC do?
Carlsmed, Inc. engages in the development of AI based technology solutions to the medical industry. The company is headquartered in Carlsbad, California and currently employs 127 full-time employees. The company went IPO on 2025-07-23. Its aprevo technology platform offers solutions for the entire surgical workflow, including pre-operative AI-enabled, surgical planning; intra-operative advanced visualization to support precision placement of aprevo interbody implants, and post-operative data collection and insights intended to improve the digital surgical planning process. Its pre-operative planning software utilizes standard-of-care diagnostic imaging and AI-enabled algorithms to develop personalized digital surgical plans and to design aprevo interbody implants for each patient's pathology and vertebral bone topography. Additionally, the aprevo technology platform supports the collection of real-world, post-operative data to inform its digital surgical planning process. Its platform is commercially available in the United States and is indicated for use in lumbar interbody fusion procedures.
Can you provide the latest stock price for CARLSMED INC?
The current stock price of CARL is 10.8 USD. The price increased by 0.47% in the last trading session.
What is the dividend status of CARLSMED INC?
CARL does not pay a dividend.
How is the ChartMill rating for CARLSMED INC?
CARL has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Is CARLSMED INC (CARL) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on CARL.
What is CARLSMED INC worth?
CARLSMED INC (CARL) has a market capitalization of 288.68M USD. This makes CARL a Micro Cap stock.
Can you provide the ownership details for CARL stock?
You can find the ownership structure of CARLSMED INC (CARL) on the Ownership tab.